| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.004 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |